Investor Says Endo Lied About Role In NY Opioid Crisis
An Endo International PLC investor launched a proposed class action Monday claiming the drugmaker's stock dropped nearly 15% after allegations surfaced about the company's role in New York's opioid crisis, unearthing...To view the full article, register now.
Already a subscriber? Click here to view full article